CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-18). The draft was written by AI, the existence of all 1 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2840 · Search date 2026-08-18 · Methodology v0.7

PeniMaster PRO penile traction device,
does it really help with Reduction of erect curvature in stable Peyronie's disease?

30-Second Summary
C
Evidence Grade C · 50 · Safety caution
Curvature improved over 12 weeks, but sexual-function benefit and durability remain uncertain
Long wear is burdensome and 43% reported local discomfort or glans numbness. Specialist guidance and regular breaks are needed to reduce edema, overstretching pain, and skin or tissue injury.
What the
research shows
The grade is C with 50 points. Among completers, curvature fell from 72.3 to 41.1 degrees with traction, a 31.2-degree reduction, while the no-intervention group changed from 68.7 to 66.3 degrees. Erect angle is a surrogate and the trial was small and completer-only.
What the
ads claim
Penile traction devices are sold online in South Korea. Direct applicability is limited to stable unidirectional curvature of at least 45 degrees without erectile dysfunction or significant pain.
*

Useful facts when choosing a product

  • PeniMaster PRO is an MSP Concept trade name using vacuum glans fixation and rod traction.
  • Mean adherence was 5.2 hours per day, a substantial burden.
  • Local discomfort or glans numbness occurred in 43%; two men with glans edema and one with overstretching pain discontinued. Removal every two hours was advised to reduce tissue injury.
Gap Measurement · Verdict 2840 · C 50
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Six hospitals randomized 93 men to traction for 3 to 8 hours daily or no-intervention observation. Device blinding was impossible, but "Patients were assessed by an independent examiner in every centre who was blind to the assignment group", so an unblinded subjective endpoint does not apply. A no-treatment control was feasible and was used. Limitation 1: small study (total under 200). Listed item: 93 participants. Avoidability: possible - multicenter recruitment could have exceeded 200. Limitation 2: completer analysis. Listed item: only 80/93, 41 versus 39, completed and entered efficacy analysis. Avoidability: possible - all 93 could have been included in ITT with missing-data sensitivity analyses. Substantial attrition (>=15%) was 13/93 (14.0%), below threshold. Short duration (<12 weeks) does not apply because follow-up was 12 weeks. The conflict statement says, "Penimaster PRO was provided free of cost to all patients", without naming the provider. Confirmed in-kind study devices prevent an independent-funding classification.

02

Why this is classified as C (50)

Erect curvature is a surrogate that caps the grade at C. A blinded examiner and large short-term change are balanced against 93 participants, completer-only efficacy analysis, and free branded devices, giving C with 50 points.

Counterpoint. The trial did not establish durable benefit or definite improvement in penetration or avoidance of surgery.

Rejudgment record. New verdict — Blinded curvature measurement and a large short-term change, but 93 participants, 80 completers, and free branded study devices

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI1Mixed funding sources
Effect sizeE+Meets the clinically important threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Reduction in erect curvature at 12 weeksCMean curvature fell by 31.2 degrees.
Improved erectile functionDIIEF-EF did not significantly differ from control.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Multicenter randomized open no-treatment-controlled trial with blinded assessors39PeniMaster PRO supplied free to all patients; provider not namedChange in goniometric curvature during alprostadil-induced erectionTraction fell from 72.3 to 41.1 degrees, a 31.2-degree reduction; no intervention changed from 68.7 to 66.3 degreesPivotal single surrogate-endpoint trial
§

Receipt — 1 References

All 1 cited sources were verified for existence at the original page (as of 2026-08-18).

Moncada I, Krishnappa P, Romero J, et al. Penile traction therapy with the new device 'Penimaster PRO' is effective and safe in the stable phase of Peyronie's disease. BJU Int. 2019;123:694-702. PMID: 30365247.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-18 · Corrections: none

Cite this verdict

PeniMaster PRO Penile Traction Improves Erect Curvature in Stable Peyronie's Disease - Benefit Evidence Grade C card
[Chamgap] PeniMaster PRO Penile Traction Improves Erect Curvature in Stable Peyronie's Disease - Benefit — Evidence Grade C·50. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/mens/penimaster-pro-traction-stable-peyronie-erect-curvature/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.